World's Best Scientists 2026 revealed!
Lawrence A. Leiter

Lawrence A. Leiter

D-Index & Metrics

Medicine

D-Index
143
Citations
101795
World Ranking
1478
National Ranking
45

Overview

Lawrence A. Leiter is affiliated with the University of Toronto in Canada and has a research focus primarily in the field of Medicine, with significant contributions in Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Molecular Biology, and Economics and Econometrics. Their work spans multiple interconnected areas reflecting interdisciplinary approaches within medical science.

The scientist's research concentrates strongly on topics such as Diabetes Treatment and Management, Lipoproteins and Cardiovascular Health, Metabolism, Diabetes, and Cancer, Diabetes Management and Research, Diet and metabolism studies, Diabetes, Cardiovascular Risks, and Lipoproteins, as well as Pancreatic function and diabetes.

Lawrence A. Leiter has published extensively in high-profile journals, with frequent publication venues including:

  • Journal of the American College of Cardiology
  • Circulation
  • Diabetes Obesity and Metabolism
  • Diabetes Care
  • European Heart Journal

Among recent notable papers authored or co-authored by Leiter are:

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure (2020) - New England Journal of Medicine
  • Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol (2020) - New England Journal of Medicine
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease (2020) - New England Journal of Medicine
  • 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults (2021) - Canadian Journal of Cardiology
  • Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia (2020) - New England Journal of Medicine

Lawrence A. Leiter collaborates frequently with several researchers, indicating strong scientific networks in their discipline. Notable co-authors include:

  • Deepak L. Bhatt
  • Kausik K. Ray
  • Darren K. McGuire
  • Wolfgang Köenig
  • Frederick J. Raal

Best Publications

  • Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

    Steven P. Marso;Stephen C. Bain;Agostino Consoli;Freddy G. Eliaschewitz

  • Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    Benjamin M. Scirica;Deepak L. Bhatt;Deepak L. Bhatt;Eugene Braunwald;P. Gabriel Steg

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

    Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Deepak L. Bhatt;Michael Szarek;P. Gabriel Steg;Christopher P. Cannon

  • 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

    Todd J. Anderson;Jean Grégoire;Glen J. Pearson;Arden R. Barry

  • Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol

    Kausik K. Ray;R. Scott Wright;David Kallend;Wolfgang Koenig;Wolfgang Koenig

  • Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.

    Kausik K Ray;Ulf Landmesser;Lawrence A Leiter;David Kallend

  • Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Salim Yusuf;Jackie Bosch;Gilles Dagenais;Jun Zhu

  • Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

    William T Cefalu;William T Cefalu;Lawrence A Leiter;Kun-Ho Yoon;Pablo Arias

  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

    Deepak L. Bhatt;Michael Szarek;Bertram Pitt;Christopher P. Cannon

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein

    David J. A. Jenkins;Cyril W. C. Kendall;Augustine Marchie;Dorothea A. Faulkner

  • Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Eva M. Lonn;Eva M. Lonn;Jackie Bosch;Jackie Bosch;Patricio Lopez-Jaramillo;Jun Zhu

  • Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.

    Thomas A. Zelniker;Stephen D. Wiviott;Itamar Raz;KyungAh Im

  • Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

    Kara A. Nerenberg;Kelly B. Zarnke;Alexander A. Leung;Kaberi Dasgupta

  • Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

    Frederick J. Raal;David Kallend;Kausik K. Ray;Traci Turner

Frequent Co-Authors

Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Shaun G. Goodman
Shaun G. Goodman University of Toronto
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
Kausik K. Ray
Kausik K. Ray Imperial College London
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Stephen D. Wiviott
Stephen D. Wiviott Brigham and Women's Hospital
Cyril W.C. Kendall
Cyril W.C. Kendall University of Toronto
John P.H. Wilding
John P.H. Wilding University of Liverpool
Subodh Verma
Subodh Verma University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers besides traditional medical school, a variety of flexible online degree options are available. Advancements in technology have made it possible to pursue programs like nursing school online, allowing students to balance education with work and personal commitments.

Registered Nurses looking to enhance their credentials may consider an rn to bsn online program, which offers the opportunity to advance in clinical practice or leadership roles. For those aiming to teach or reach the highest levels of nursing, accredited doctorate in nursing education online programs provide advanced skills in research, policy, and academia.

Even those without a prior nursing background can take advantage of direct entry online msn programs designed for non-nurses, accelerating entry into nursing careers. These flexible online pathways can open doors to rewarding roles in patient care, administration, and education within the growing U.S. healthcare system.

Best Scientists Citing Lawrence A. Leiter

Trending Scientists